Pretium Resources Inc (PVG)

KYG7613T1031 - Common Stock

15.05  -0.2 (-1.31%)

After market: 15.1 +0.05 (+0.33%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to PVG. PVG was compared to 156 industry peers in the Metals & Mining industry. Both the profitability and financial health of PVG have multiple concerns. PVG is valied quite expensively at the moment, while it does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

PVG had positive earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA -2.32%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 31.65%
PM (TTM) -4.7%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

PVG has more shares outstanding than it did 1 year ago.
The debt/assets ratio for PVG has been reduced compared to a year ago.

2.2 Solvency

An Altman-Z score of 4.76 indicates that PVG is not in any danger for bankruptcy at the moment.
A Debt/Equity ratio of 0.09 indicates that PVG is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Altman-Z 4.76
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

PVG has a Current Ratio of 1.28. This is a normal value and indicates that PVG is financially healthy and should not expect problems in meeting its short term obligations.
A Quick Ratio of 1.13 indicates that PVG should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 1.13

4

3. Growth

3.1 Past

PVG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.47%.
The Earnings Per Share has been growing by 121.20% on average over the past years. This is a very strong growth
Looking at the last year, PVG shows a small growth in Revenue. The Revenue has grown by 4.72% in the last year.
PVG shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 51.42% yearly.
EPS 1Y (TTM)-16.47%
EPS 3Y121.2%
EPS 5YN/A
EPS growth Q2Q-51.85%
Revenue 1Y (TTM)4.72%
Revenue growth 3Y51.42%
Revenue growth 5YN/A
Revenue growth Q2Q-5.21%

3.2 Future

The Earnings Per Share is expected to decrease by -3.85% on average over the next years.
PVG is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.24% yearly.
EPS Next Y-38.93%
EPS Next 2Y-7.77%
EPS Next 3Y-11.8%
EPS Next 5Y-3.85%
Revenue Next Year0.02%
Revenue Next 2Y5.24%
Revenue Next 3Y1.08%
Revenue Next 5Y1.24%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 21.20, PVG is valued on the expensive side.
Compared to an average S&P500 Price/Earnings ratio of 28.60, PVG is valued a bit cheaper.
With a Price/Forward Earnings ratio of 18.62, PVG is valued on the expensive side.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.15, PVG is valued at the same level.
Industry RankSector Rank
PE 21.2
Fwd PE 18.62

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.51

4.3 Compensation for Growth

A cheap valuation may be justified as PVG's earnings are expected to decrease with -11.80% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-7.77%
EPS Next 3Y-11.8%

0

5. Dividend

5.1 Amount

No dividends for PVG!.
Industry RankSector Rank
Dividend Yield N/A

Pretium Resources Inc

NYSE:PVG (3/8/2022, 7:22:34 PM)

After market: 15.1 +0.05 (+0.33%)

15.05

-0.2 (-1.31%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.83B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 21.2
Fwd PE 18.62
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.32%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM 31.65%
PM (TTM) -4.7%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.28
Quick Ratio 1.13
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-16.47%
EPS 3Y121.2%
EPS 5Y
EPS growth Q2Q
EPS Next Y-38.93%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)4.72%
Revenue growth 3Y51.42%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y